Delivery Order SPE2DB20D2104-SPE2DB23FS63W
Award Date 3/16/23
Potential Completion Date 3/17/23
Potential Value $1.5K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,714.39 firm fixed-price delivery order is for the supply of LIALDA DR 1.2 GM TABLET 120S, a pharmaceutical product. The contract has an ultimate completion date of October 13, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award, valued at $22,741.55, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of 4,566,065,418 tablets of the prescription medication Lialda, a 1.2 gram delayed-release tablet, in quantities of 120 per package. This is a firm-fixed price delivery order contract with an ultimate completion date of October 10, 2024. The contract does not have a set-aside designation. Amerisourcebergen...
- This is a $1,471.80 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of LIALDA DR 1.2 GM TABLET 120S, a pharmaceutical product. The contract has a completion date of July 10, 2025 and is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,049.08 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical sourcing and distribution company. The contract is for the delivery of 120 tablets of the prescription medication LIALDA DR 1.2 GM with a completion date of February 2, 2024. This delivery order is part of Amerisourcebergen Drug Corp's larger $999,999,999.00 indefinite delivery contract with...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of 4,566,150 units of the prescription drug Lialda (mesalamine) in 120-count tablet bottles. The $2,807.73 firm fixed-price contract has an ultimate completion date of October 21, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as a primary vehicle...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The order is for the pharmaceutical product Lialda DR 1.2 GM Tablet 120S, with a ceiling value of $3,410.52 and a period of performance through April 12, 2024. No set-aside designation was used for this award. AmerisourceBergen Drug Corp is the prime contractor and serves as a supplier of pharmaceuticals, medical supplies, and...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,351.56 to AmerisourceBergen Drug Corp for LIALDA DR 1.2 GM tablets (120-count supply) on December 17, 2025, with completion scheduled for December 18, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX). The contract will be performed at AmerisourceBergen's...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,696.67 contract is for the supply of 120 tablets of the drug Lialda (mesalamine 1.2 gram) to support military and federal healthcare programs. The award is not designated as a set-aside contract. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, as...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, contract number SPE2DB20D1004|SPE2DB21FF8X7, is for the delivery of Lialda DR 1.2 GM Tablets in quantities of 120. The award has a ceiling value of $8,580.44 and an ultimate completion date of August 2, 2021. This is a delivery order contract with a firm fixed price pricing type. Amerisourcebergen Drug Corp...
- This federal contract award is for the delivery of pharmaceutical products, specifically the drug Lialda, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a delivery order with a firm fixed price of $1,058.76 and a completion date of August 23, 2021. The contract was awarded on August 20, 2021, and there is no set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical...